Literature DB >> 20587207

Human Brucella canis infections diagnosed by blood culture.

Atsushi Nomura, Koichi Imaoka, Hajime Imanishi, Hideaki Shimizu, Fumiko Nagura, Kayaho Maeda, Tatsuhito Tomino, Yoshiro Fujita, Masanobu Kimura, Gerald Stein.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20587207      PMCID: PMC3321888          DOI: 10.3201/eid1607.090209

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Brucellosis is a worldwide zoonosis caused by Brucella spp. The 4 species known to infect humans are B. melitensis, B. suis, B. abortus, and B. canis (). Since 1999, 11 cases in Japan have been reported. Although no bacteria were isolated, serum antibody detection indicated that 4 were caused by B. melitensis or B. abortus acquired abroad and the other 7 by B. canis (). Of these 7 patients, 2 were presumed to have received their infection from dogs, and the sources of infection for the other 5 are unclear. We report 2 cases of B. canis infection diagnosed by blood culture. Patient 1 was a 71-year-old male pet shop manager with hypertension. He came to Chubu Rosai Hospital, Nagoya, Japan, on August 9, 2008, after having fever and fatigue for 3 weeks, which were nonresponsive to third-generation cephalosporins. At the time of admission, his temperature was 37.8°C, but physical examination findings were unremarkable. On day 2, gram-negative coccobacilli were detected in a culture of blood collected at the time of admission. Ceftriaxone (1 g 1×/d) was administered, but fever persisted. On day 5, coccobacilli were growing poorly on culture media. Because the patient’s history indicated the possibility of a zoonotic disease, doxycycline (100 mg 2×/d) was administered. Thereafter, the patient’s fever and generalized symptoms resolved. The blood specimen and isolated bacteria were sent to the National Institute of Infectious Disease, B. canis was identified by combinatorial PCR (). Serum tube agglutination test indicated an antibody titer against B. canis of 1,280 (Table). On day 10, streptomycin (1 g 1×/d) was added to the treatment regimen. On day 33, the patient was discharged; his laboratory values were almost within reference limits, and he continued taking doxycycline for 6 weeks and streptomycin for 2 weeks.
Table

Laboratory data for 2 patients infected with Brucella canis, Japan, 2008

Patient no.Isolation of B. canis by blood cultureB. canis titer (date of sample collection)*B. abortus titer (date of sample collection)*
1+
1,280 (Aug 11)<40 (Aug 11)
1,280 (Sep 30)

320(Nov 4)
2+320 (Aug 19)<40 (Aug 19)
320 (Oct 7)
160 (Nov 11)

*Titers determined by serum tube agglutination test.

*Titers determined by serum tube agglutination test. Patient 2, a previously healthy 44-year-old co-worker of patient 1, exhibited similar signs and symptoms—fever and general fatigue—that started around the same time as for patient 1 (3 weeks before August 9, 2008). Physical examination findings at that time were unremarkable. Blood tests indicated moderate liver dysfunction. Treatment with fosfomycin was not effective. On August 19, the day after the diagnosis of brucellosis was made for patient 1, patient 2 came to Chubu Rosai Hospital, where B. canis was identified from blood culture. Serum antibody titer was 320 (Table). This patient was treated with doxycycline (100 mg 2×/d) plus rifampin (600 mg 1×/d) for 6 weeks. All signs, symptoms, and liver dysfunction resolved. Neither patient had an immune disorder. About 2 months before illness onset they had each handled, without protection, the placenta of an aborted dog fetus. Negative antibody results were obtained for other persons at risk for infection: laboratory workers who were exposed to the patients’ specimens, the patients’ families, and a veterinarian who had been stuck by a needle when collecting blood from pet shop dogs to examine for antibody against B. canis. We prescribed doxycycline plus rifampin for 3 laboratory workers because brucellosis is among the most commonly reported laboratory-acquired bacterial infections and because postexposure prophylaxis is recommended for persons at high risk for exposure (). Several days after identification of B. canis for patient 1, the dogs in the pet shop (37 dogs, 23 adults and their 14 puppies) were examined for antibody against B. canis by using the microplate agglutination test () and for the B. canis­­–specific gene by combinatorial PCR (). A total of 6 dogs were positive for antibody (titers 320–5,120) and the specific gene; 5 were positive for antibody only (titers 320–5,120), and 4 were positive for the specific gene only. Only adult dogs had positive results. Blood cultures were positive for 6 dogs that were antibody positive. Dogs that were determined by any method to be infected and their puppies (with negative test results) were euthanized. Since January 2008, a total of 8 puppies from the infected dogs had been sold; they were located, tested, and found to not have antibody against B. canis. The local government reported this information to the Ministry of Health, Labour and Welfare, Japan, and the ministry shared the information with related organizations. Caution is necessary when basing diagnosis on serum tube agglutination test because B. canis has rough surface antigen and does not cross-react with B. abortus antigen (smooth Brucella spp.), which is usually used to diagnose brucellosis (). Furthermore, because brucellosis is relatively rare and signs and symptoms are nonspecific, the number of cases reported is thought to be underestimated (–). A recent report showed that 2.5% of dogs in Japan have antibody against B. canis, but adult dogs are rarely seriously ill despite this generalized systemic infection (,). Thus, if a febrile person has signs and symptoms of unknown cause and a history of close contact with dogs, brucellosis should be considered and appropriate action to prevent spread of infection should be taken.
  6 in total

Review 1.  Brucellosis.

Authors:  Georgios Pappas; Nikolaos Akritidis; Mile Bosilkovski; Epameinondas Tsianos
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

2.  Simultaneous detection of the genus Brucella by combinatorial PCR.

Authors:  Koichi Imaoka; Masanobu Kimura; Michio Suzuki; Tsuneo Kamiyama; Akio Yamada
Journal:  Jpn J Infect Dis       Date:  2007-05       Impact factor: 1.362

3.  Diagnosis of human brucellosis caused by Brucella canis.

Authors:  Nidia E Lucero; Gabriela I Escobar; Sandra M Ayala; Nestor Jacob
Journal:  J Med Microbiol       Date:  2005-05       Impact factor: 2.472

4.  Evaluation of a microplate agglutination test (MAT) for serological diagnosis of canine brucellosis.

Authors:  Masanobu Kimura; Koichi Imaoka; Michio Suzuki; Tsuneo Kamiyama; Akio Yamada
Journal:  J Vet Med Sci       Date:  2008-07       Impact factor: 1.267

5.  Laboratory-acquired brucellosis--Indiana and Minnesota, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-01-18       Impact factor: 17.586

Review 6.  Human brucellosis.

Authors:  María Pía Franco; Maximilian Mulder; Robert H Gilman; Henk L Smits
Journal:  Lancet Infect Dis       Date:  2007-12       Impact factor: 25.071

  6 in total
  17 in total

1.  Human Brucella canis Infection and Subsequent Laboratory Exposures Associated with a Puppy, New York City, 2012.

Authors:  C M Dentinger; K Jacob; L V Lee; H A Mendez; K Chotikanatis; P L McDonough; D M Chico; B K De; R V Tiller; R M Traxler; E R Campagnolo; D Schmitt; M A Guerra; S A Slavinski
Journal:  Zoonoses Public Health       Date:  2014-11-01       Impact factor: 2.702

2.  Detection of Brucella spp. in dogs at Pantanal wetlands.

Authors:  Ana Laura Bello de Oliveira; Gabriel Carvalho de Macedo; Gracia Maria Soares Rosinha; Jhessyca Leal Melgarejo; Andreza Gabriela Leão Alves; Wanessa Teixeira Gomes Barreto; Filipe Martins Santos; João Bosco Vilela Campos; Heitor Miraglia Herrera; Carina Elisei de Oliveira
Journal:  Braz J Microbiol       Date:  2018-12-10       Impact factor: 2.476

3.  The first case of Brucella canis in Sweden: background, case report and recommendations from a northern European perspective.

Authors:  Bodil Ström Holst; Karin Löfqvist; Linda Ernholm; Karin Eld; Maria Cedersmyg; Gunilla Hallgren
Journal:  Acta Vet Scand       Date:  2012-03-27       Impact factor: 1.695

4.  Seroprevalence of Brucella canis antibodies in dogs entering a Minnesota humane society, Minnesota, 2016-2017.

Authors:  Tory V Whitten; Graham Brayshaw; Devi Patnayak; Julio Alvarez; Christina M Larson; Margaret Root Kustritz; Stacy M Holzbauer; Jerry Torrison; Joni M Scheftel
Journal:  Prev Vet Med       Date:  2019-04-29       Impact factor: 2.670

Review 5.  Brucellosis in the Brazilian Pantanal wetland: threat to animal production and wildlife conservation.

Authors:  Gabriel Carvalho de Macedo; Heitor Miraglia Herrera; Grasiela Edith de Oliveira Porfírio; Filipe Martins Santos; William Oliveira de Assis; Gisele Braziliano de Andrade; Wesley Arruda Gimenes Nantes; Javier Hermoso de Mendoza; Pedro Fernández-Llario; Carina Elisei de Oliveira
Journal:  Braz J Microbiol       Date:  2022-10-21       Impact factor: 2.214

6.  Serological trail of Brucella infection in an urban slum population in Brazil.

Authors:  Martha Olivera Angel; Paula Ristow; Albert Icksang Ko; Cecilia Di-Lorenzo
Journal:  J Infect Dev Ctries       Date:  2012-09-17       Impact factor: 0.968

7.  Brucella suis infection in dogs, Georgia, USA.

Authors:  Sheela Ramamoorthy; Moges Woldemeskel; Alan Ligett; Ron Snider; Robert Cobb; Sreekumari Rajeev
Journal:  Emerg Infect Dis       Date:  2011-12       Impact factor: 6.883

8.  MLVA and LPS Characteristics of Brucella canis Isolated from Humans and Dogs in Zhejiang, China.

Authors:  Dongri Piao; Heng Wang; Dongdong Di; Guozhong Tian; Jiantong Luo; Wenjie Gao; Hongyan Zhao; Weimin Xu; Weixing Fan; Hai Jiang
Journal:  Front Vet Sci       Date:  2017-12-18

9.  Proinflammatory response of canine trophoblasts to Brucella canis infection.

Authors:  Andrea G Fernández; M Soledad Hielpos; Mariana C Ferrero; Carlos A Fossati; Pablo C Baldi
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

10.  Genetic polymorphism characteristics of Brucella canis isolated in China.

Authors:  Dongdong Di; Buyun Cui; Heng Wang; Hongyan Zhao; Dongri Piao; Lili Tian; Guozhong Tian; Jingli Kang; Xiang Mao; Xiaojun Zhang; Pengfei Du; Lin Zhu; Zhuo Zhao; Lingling Mao; Wenqing Yao; Pingyuan Guan; Weixing Fan; Hai Jiang
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.